Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.81 +0.02 (+1.89%)
As of: Oct 2, 2026 · 9:42 AM EDT

Rani Therapeutics Holdings (RANI) Receivables - Net (2025 - 2026)

Updated

Rani Therapeutics Holdings (RANI) recorded Receivables - Net of $2.04 million in Q2 2026, unchanged from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Receivables - Net (2025 - 2026) Analysis & Trends

Starting with Q1 2025, Rani Therapeutics Holdings' Receivables - Net history includes 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.04 Mn
Mar 31, 2026 2.04 Mn
Dec 31, 2025 2.04 Mn
Mar 31, 2025 600,000.00
API Access

Rani Therapeutics Holdings Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=RANI&period=max&api_key=YOUR_API_KEY